• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有内在治疗活性的功能性胶束载体用于抗癌药物递送的研究进展

Recent Progress in Functional Micellar Carriers with Intrinsic Therapeutic Activities for Anticancer Drug Delivery.

作者信息

Qu Ying, Chu BingYang, Shi Kun, Peng JinRong, Qian ZhiYong

出版信息

J Biomed Nanotechnol. 2017 Dec 1;13(12):1598-1618. doi: 10.1166/jbn.2017.2475.

DOI:10.1166/jbn.2017.2475
PMID:29490750
Abstract

Polymeric micelles have presented superior delivery properties for poorly water-soluble chemotherapeutic agents. However, it remains discouraging that there may be some additional short or long-term toxicities caused by the metabolites of high quantities of carriers. If carriers had simultaneous therapeutic effects with the drug, these issues would not be a concern. For this, carriers not only simply act as drug carriers, but also exert an intrinsic therapeutic effect as a therapeutic agent. The functional micellar carriers would be beneficial to maximize the anticancer effect, overcome the drug resistance and reduce the systemic toxicity. In this review, we aim to summarize the recent progress on the development of functional micellar carriers with intrinsic anticancer activities for the delivery of anticancer drugs. This review focuses on the design strategies, properties of carriers and the drug loading behavior. In addition, the combinational therapeutic effects between carriers and chemotherapeutic agents are also discussed.

摘要

聚合物胶束对水溶性差的化疗药物具有优异的递送性能。然而,大量载体的代谢产物可能会引起一些额外的短期或长期毒性,这仍然令人沮丧。如果载体能与药物同时发挥治疗作用,这些问题就不会成为关注点。为此,载体不仅简单地充当药物载体,还作为治疗剂发挥内在治疗作用。功能性胶束载体将有利于最大化抗癌效果、克服耐药性并降低全身毒性。在本综述中,我们旨在总结用于递送抗癌药物的具有内在抗癌活性的功能性胶束载体开发的最新进展。本综述重点关注设计策略、载体性质和药物负载行为。此外,还讨论了载体与化疗药物之间的联合治疗效果。

相似文献

1
Recent Progress in Functional Micellar Carriers with Intrinsic Therapeutic Activities for Anticancer Drug Delivery.具有内在治疗活性的功能性胶束载体用于抗癌药物递送的研究进展
J Biomed Nanotechnol. 2017 Dec 1;13(12):1598-1618. doi: 10.1166/jbn.2017.2475.
2
Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.来自水溶性聚合物脂质衍生物的胶束作为难溶性药物的递送系统。
Adv Drug Deliv Rev. 2004 May 7;56(9):1273-89. doi: 10.1016/j.addr.2003.12.004.
3
Amphiphilic polymeric micelles as the nanocarrier for peroral delivery of poorly soluble anticancer drugs.两亲性聚合物胶束作为口服递送难溶性抗癌药物的纳米载体。
Expert Opin Drug Deliv. 2012 Jun;9(6):687-700. doi: 10.1517/17425247.2012.681299. Epub 2012 Apr 20.
4
Current trends in the use of vitamin E-based micellar nanocarriers for anticancer drug delivery.基于维生素E的胶束纳米载体用于抗癌药物递送的当前趋势。
Expert Opin Drug Deliv. 2017 Jun;14(6):715-726. doi: 10.1080/17425247.2016.1229300. Epub 2016 Sep 6.
5
[Advances in polymer-drug conjugated micelles in the delivery of anticancer drugs].[聚合物-药物共轭胶束在抗癌药物递送中的研究进展]
Yao Xue Xue Bao. 2016 May;51(5):710-6.
6
Polymeric micelles: nanocarriers for cancer-targeted drug delivery.聚合物胶束:用于癌症靶向给药的纳米载体。
AAPS PharmSciTech. 2014 Aug;15(4):862-71. doi: 10.1208/s12249-014-0113-z. Epub 2014 Apr 4.
7
mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.甲氧基聚乙二醇化茄尼醇胶束作为具有协同抗癌作用的氧化还原响应性纳米载体。
Acta Biomater. 2017 Dec;64:211-222. doi: 10.1016/j.actbio.2017.09.040. Epub 2017 Sep 27.
8
Polymeric micelles for anticancer drug delivery.用于抗癌药物递送的聚合物胶束。
Ther Deliv. 2020 Oct;11(10):613-635. doi: 10.4155/tde-2020-0008. Epub 2020 Sep 15.
9
Dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery.用于抗癌药物递送的双温敏和pH响应性自组装胶束纳米凝胶
Drug Deliv. 2014 Jun;21(4):258-64. doi: 10.3109/10717544.2013.838717. Epub 2013 Oct 9.
10
Multifunctional nanomicellar systems for delivering anticancer drugs.用于递送抗癌药物的多功能纳米胶束系统。
J Biomed Mater Res A. 2014 Jun;102(6):2024-38. doi: 10.1002/jbm.a.34850. Epub 2013 Jul 5.

引用本文的文献

1
Polymer Micelles as Nanocarriers of Bioactive Peptides.聚合物胶束作为生物活性肽的纳米载体
Polymers (Basel). 2025 Apr 25;17(9):1174. doi: 10.3390/polym17091174.
2
Drug self-delivery systems: A comprehensive review on small molecule nanodrugs.药物自递送系统:小分子纳米药物综述
Bioimpacts. 2024 Oct 27;15:30161. doi: 10.34172/bi.30161. eCollection 2025.
3
Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines.临床试验中的纳米颗粒:临床试验分析、FDA 批准情况以及在 COVID-19 疫苗中的应用。
Int J Mol Sci. 2023 Jan 2;24(1):787. doi: 10.3390/ijms24010787.
4
Physically stimulus-responsive nanoparticles for therapy and diagnosis.用于治疗和诊断的物理刺激响应性纳米颗粒。
Front Chem. 2022 Sep 14;10:952675. doi: 10.3389/fchem.2022.952675. eCollection 2022.
5
Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma.基于脂质体的多功能纳米平台作为治疗视网膜母细胞瘤的有效疗法。
Acta Pharm Sin B. 2022 Jun;12(6):2731-2739. doi: 10.1016/j.apsb.2021.10.009. Epub 2021 Oct 22.
6
PEG-Derivatized Dual-Functional Nanomicelles for Improved Cancer Therapy.用于改善癌症治疗的聚乙二醇衍生化双功能纳米胶束
Front Pharmacol. 2019 Jul 19;10:808. doi: 10.3389/fphar.2019.00808. eCollection 2019.
7
Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy.具有吲哚美辛侧基的双重功能免疫刺激聚合物前药载体用于增强癌症免疫化疗。
Acta Biomater. 2019 May;90:300-313. doi: 10.1016/j.actbio.2019.03.048. Epub 2019 Mar 28.
8
Naturally-Derived PHA-L Protein Nanoparticle as a Radioprotector Through Activation of Toll-Like Receptor 5.天然衍生的PHA-L蛋白纳米颗粒通过激活Toll样受体5作为辐射防护剂
J Biomed Nanotechnol. 2019 Jan 1;15(1):62-76. doi: 10.1166/jbn.2019.2665.
9
Mechanisms of enhanced antiglioma efficacy of polysorbate 80-modified paclitaxel-loaded PLGA nanoparticles by focused ultrasound.聚山梨酯 80 修饰的紫杉醇载 PLGA 纳米粒通过聚焦超声增强抗神经胶质瘤疗效的机制。
J Cell Mol Med. 2018 Sep;22(9):4171-4182. doi: 10.1111/jcmm.13695. Epub 2018 Jun 29.
10
Human Albumin Fragments Nanoparticles as PTX Carrier for Improved Anti-cancer Efficacy.人白蛋白片段纳米颗粒作为紫杉醇载体以提高抗癌疗效
Front Pharmacol. 2018 Jun 12;9:582. doi: 10.3389/fphar.2018.00582. eCollection 2018.